Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Board Appointment

1 Feb 2005 12:00

Cello Group plc01 February 2005 1 February 2005 Cello Group plc Board Appointment The board of Cello Group plc ("Cello") announces the appointment of Mark Bentleyas Group Finance Director and Company Secretary. It is expected that he willjoin the board in late April, subject to existing contractual obligations. Mark Bentley (34) is currently Chief Operating Officer of Citigate Dewe RogersonLimited and Finance Director of Citigate SMARTS Group, part of Incepta Groupplc. Prior to this, he was Financial Projects Manager at Hodder Headline plc.He qualified as a chartered accountant with PriceWaterhouseCoopers in 1996. Commenting on his appointment, Kevin Steeds, Chairman of Cello said: "We lookforward to welcoming Mark to the Group. He combines the traditional professionalfinancial background with some excellent operational experience in the marketingservices industry. I am sure he will play a key role in the future growth plansof Cello" - ENDS - Enquiries: Kevin Steeds - Chairman - Cello Group plc Tel: 020 7324 6120 Adrian Duffield - College Hill Tel: 020 7457 2020 Notes to Editors:- (www.cellogroup.co.uk) Cello Group plc, a newly incorporated marketing services group which listed onAIM in November 2004 and comprises four businesses which operate in threedifferent niches of the marketing services sector: - healthcare market research,direct and database marketing and brand advertising. Each share significantorganic and acquisitive growth potential; blue chip client lists and a longtrack record of client loyalty; experienced, high quality management teams;profitability; and potential for enhancing gross margins. Market research • Insight is a specialist healthcare market research business employing some 75 people and has offices in central London and New Jersey. Its clients include GlaxoSmithKline, Novartis, AstraZeneca, Shire Pharmaceuticals, NovoNordisk, Boehringer Ingleheim, Lundbeck, Pfizer, Roche and Merck, Sharp and Dohme. Brand advertising • Leith is the largest and most successful advertising agency in Scotland employing 60 people. The agency has been voted Scottish Agency of the Year for the last five years. Leith opened a London office in 2000 which has grown from a start-up to 25 people. Leith's major clients are Standard Life, Irn Bru, Scottish Executive, Standard Life Bank, Hotpoint, Goodfellas Pizza and Carling. Direct marketing and database management • Target, based in Cheltenham, is the UK's leading direct marketing consultancy specialising in the "not-for-profit" and charity sector. The agency works for five of the top 20 charities in the UK and employs some 80 people. Target has also expanded its offer to the "grey market", working for clients such as The National Trust, Saga Holidays and Which? Limited. Target's subsidiary, Talking Numbers is a leading database management and analytics company. • Navigator Responsive Advertising is Scotland's number one direct marketing company employing 40 people and provides responsive communication solutions for a wide range of clients. Areas of expertise include strategic planning, database marketing, customer relationship management and creative solutions - utilising a wide range of media that includes direct mail, press, outdoor, radio, DRTV and electronic media. Navigator was a winner of eight industry awards in 2004. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Aug 20201:38 pmRNSForm 8.3 - Cello Health Plc
11th Aug 202012:05 pmRNSForm 8.3 - Cello Health Plc
11th Aug 202011:34 amRNSForm 8.3 - [Cello Health plc]
11th Aug 202010:07 amRNSScheme of Arrangement becomes Effective
11th Aug 20208:49 amPRNForm 8.3 - Cello Health Plc
11th Aug 20207:30 amRNSSuspension - Cello Health Plc
10th Aug 20202:30 pmRNSForm 8 (DD) - Cello Health plc
10th Aug 20202:30 pmRNSForm 8 (DD) - Cello Health plc
10th Aug 20202:30 pmRNSForm 8 (DD) - Cello Health plc
10th Aug 20202:30 pmRNSForm 8 (DD) - Cello Health plc
10th Aug 202012:12 pmRNSRelevant Securities in Issue
10th Aug 202011:02 amRNSForm 8.3 - Cello Health PLC
10th Aug 20208:54 amRNSExercise of Options
10th Aug 20208:06 amRNSForm 8.5 (EPT/NON-RI)
7th Aug 20203:16 pmRNSForm 8.3 - CELLO HEALTH PLC
7th Aug 20203:04 pmRNSCourt Sanction of Scheme
7th Aug 202012:52 pmRNSAdditional Block Listing of Ordinary Shares
6th Aug 202011:01 amRNSForm 8.3 - Cello Health PLC
5th Aug 20201:34 pmRNSForm 8.3 - Cello Health Plc
4th Aug 20205:30 pmRNSCello Health
4th Aug 202012:39 pmRNSForm 8.3 - Cello Health PLC
4th Aug 20208:21 amRNSForm 8.5 (EPT/NON-RI)
3rd Aug 202012:57 pmRNSResults of Court Meeting and General Meeting
3rd Aug 202010:53 amRNSForm 8.3 - CELLO GROUP PLC
31st Jul 202012:39 pmRNSForm 8.3 - CELLO GROUP PLC
31st Jul 202011:46 amRNSForm 8.3 - Cello Health PLC
31st Jul 20208:34 amRNSForm 8.5 (EPT/NON-RI)
31st Jul 20207:58 amRNSForm 8.3 - Cello Health PLC
30th Jul 20205:11 pmRNSHolding(s) in Company
30th Jul 20208:03 amRNSForm 8.3 - Cello Health Plc
29th Jul 202012:49 pmRNSHolding(s) in Company
29th Jul 20208:30 amRNSForm 8.5 (EPT/NON-RI)
28th Jul 20206:18 pmRNSUpdate on letters of intent
28th Jul 20203:17 pmRNSForm 8.3 - CELLO HEALTH PLC
28th Jul 20202:46 pmRNSForm 8.3 - Cello Health PLC
28th Jul 20202:04 pmRNSNotification of Major Holdings
28th Jul 20201:24 pmRNSCELLO HEALTH PLC ORD GBP0.10
28th Jul 202011:36 amGNWForm 8.3 - [Cello Health plc] - (HHL)
28th Jul 202011:17 amRNSForm 8.3 - Cello Health Plc
28th Jul 20208:45 amRNSForm 8.5 (EPT/NON-RI)
27th Jul 20203:17 pmRNSForm 8.3 - [CELLO HEALTH PLC
27th Jul 20207:00 amRNSHolding(s) in Company
23rd Jul 20203:29 pmRNSForm 8.3 - Cello Health PLC
22nd Jul 202012:33 pmRNSForm 8.3 - Cello Health PLC
22nd Jul 202011:38 amRNSFORM 8.3 - Cello Health Plc
21st Jul 20203:15 pmBUSForm 8.3 - Cello Health plc
21st Jul 20202:35 pmRNSForm 8.3 - Cello Health PLC
21st Jul 202012:18 pmRNSBlock Listing Update & Total Voting Rights
21st Jul 20207:00 amRNSHolding(s) in Company
20th Jul 20203:15 pmBUSForm 8.3 - Cello Health plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.